12,296 Shares in Trupanion, Inc. (NASDAQ:TRUP) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 12,296 shares of the financial services provider's stock, valued at approximately $593,000.

A number of other institutional investors and hedge funds have also bought and sold shares of TRUP. Invesco Ltd. raised its stake in shares of Trupanion by 122.0% in the fourth quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider's stock valued at $10,925,000 after purchasing an additional 124,549 shares in the last quarter. Aster Capital Management DIFC Ltd grew its stake in Trupanion by 988.5% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider's stock worth $55,000 after buying an additional 1,028 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in Trupanion by 41.8% during the 4th quarter. Russell Investments Group Ltd. now owns 9,172 shares of the financial services provider's stock valued at $442,000 after purchasing an additional 2,706 shares in the last quarter. Dynamic Technology Lab Private Ltd increased its stake in shares of Trupanion by 108.0% in the fourth quarter. Dynamic Technology Lab Private Ltd now owns 24,022 shares of the financial services provider's stock valued at $1,158,000 after buying an additional 12,474 shares in the last quarter. Finally, Wells Fargo & Company MN raised its stake in shares of Trupanion by 44.1% in the fourth quarter. Wells Fargo & Company MN now owns 15,798 shares of the financial services provider's stock worth $761,000 after acquiring an additional 4,836 shares during the last quarter.

Analysts Set New Price Targets

Several brokerages have weighed in on TRUP. Lake Street Capital dropped their price objective on Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a report on Friday, May 2nd. Piper Sandler lowered their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a report on Thursday, February 20th. Finally, Stifel Nicolaus dropped their price target on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $51.80.

Trupanion Stock Performance

Shares of TRUP opened at $44.61 on Thursday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm has a 50-day moving average of $36.24 and a 200-day moving average of $44.73. The company has a market cap of $1.91 billion, a PE ratio of -193.94, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a one year low of $22.96 and a one year high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $341.98 million for the quarter, compared to analysts' expectations of $337.81 million. During the same quarter in the prior year, the business earned ($0.16) EPS. The firm's revenue for the quarter was up 11.7% on a year-over-year basis. As a group, equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of the firm's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the transaction, the chief executive officer now owns 118,784 shares in the company, valued at $3,728,629.76. This trade represents a 1.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 1,373 shares of the company's stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the sale, the chief financial officer now directly owns 2,416 shares of the company's stock, valued at $82,675.52. This represents a 36.24 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,792 shares of company stock valued at $1,122,802. Insiders own 5.50% of the company's stock.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.